Arla Foods Ingredients receives approval for use of MFGM in infant formula

In a recent press release¹, Arla Foods Ingredients announced that its milk fat globule membrane (MFGM) ingredient has been approved in Australia to be used in infant formula products and that the company has obtained exclusive commercialization rights.

In Australia, Arla Foods Ingredients’ Lacprodan MFGM-10 is the company’s first early life nutrition product to receive approval. Additionally, for at least 15 months, it is the only MFGM ingredient to be approved for use in products for infants in Australia. The ingredient MFGM is found naturally in human milk and consists of gangliosides, phospholipids, and sphingolipids. According to the press release, MFGM-10 is the global formula market’s first bovine MFGM ingredient and has been shown to support immune health and infant nutrition.

The Food Standards Australia New Zealand (FSANZ) approved MFGM to be included as a nutritive substance in infant formula products on April 30, 2025.¹ The ingredient’s approval is now in effect after receiving formal acceptance by the Australia and New Zealand Food Ministers Meeting. In Australia, Lacprodan MFGM-10 is allowed to be labeled as “Milk fat globule membrane-enriched whey protein concentrate.”¹ In New Zealand, this is not the case because the country has decided to opt out of the standard used for Australia-New Zealand joint infant formula products. In the EU, Lacprodan MFGM-10 is not considered to be a novel food which allows the product to be utilized in both products for infants and adults.

“We’re proud to have pioneered the use of MFGM in infant nutrition, which has allowed significant improvements in the creation of scientifically backed formula products,” said Jakob Madsen Pedersen, senior director, specialised nutrition at Arla Foods Ingredients.¹ “Following the recent positive decision about Lacprodan MFGM-10 in the EU, this is another highly welcome regulatory development. We’re delighted that its many clinically supported benefits for infants are now also available in Australia.”

According to Innova Market Insights’ “Infant Formulat Trends: Global Market Overview” report, the formula market in Australia is one of the fastest-growing globally.² Sales in this sector are anticipated in 2029 to hit 487 million AUD.

References

1. Australia approves Arla Foods Ingredients’ mfgm for use in infant formula https://arla-foods-ingredients.prezly.com/australia-approves-arla-foods-ingredients-mfgm-for-use-in-infant-formula?utm_source=prezly.com&utm_medium=campaign&utm_campaign=PRESS+RELEASE%3A+Australia+approves+Arla+Foods+Ingredients%E2%80%99+MFGM+for+use+in+infant+formula&utm_id=7ee00c0a-ed56-40f8-8162-c9a35e5d2258&utm_content=story+title (accessed Jul 22, 2025).
2. Infant Formula Trends: Global Market Overview, Innova Market Insights, 2025 https://www.innovamarketinsights.com/trends/infant-formula-trends/ (accessed Jul 22, 2025)